Cardiogenic shock
Conditions
Interventions
Group 1:Venous continuous pump injection of Remimazolam
Sponsors
The First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Over 18 years old; 2. Patients who meet the indications and receive VA-ECMO therapy for more than 24 hours of invasive mechanical ventilation.
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity to remimazolam tosylate, taking any drug that may cause drug-drug interaction or change the concentration of remimazolam tosylate; 2. Patients with severe kidney disease in the past, chronic kidney disease history of more than 4 stages or dialysis or preoperative estimated glomerular filtration rate < 30 ml/min.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacokinetics; | — |
Secondary
| Measure | Time frame |
|---|---|
| General basic patient information;ECMO duration;Serum creatinine;Plasma pH; | — |
Countries
China
Contacts
Public ContactFen Liu
The First Affiliated Hospital of Nanchang University
Outcome results
None listed